References
- LochtCPertussis: where did we go wrong and what can we do about it?J. Infect.201672Suppl. S34S4010.1016/j.jinf.2016.04.020
- KilgorePESalimAMZervosMJSchmittHJPertussis: microbiology, disease, treatment, and preventionClin. Microbiol. Rev.20162944948610.1128/CMR.00083-154861987
- GustafssonLHallanderHOOlinPReizensteinEStorsaeterJA controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccineN. Engl. J. Med.199633434935510.1056/NEJM199602083340602
- OlinPRasmussenFGustafssonLHallanderHOHeijbelHRandomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis VaccinesLancet19973501569157710.1016/S0140-6736(97)06508-2
- van der MaasNAPertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?Vaccine2013314541454710.1016/j.vaccine.2013.07.060
- PawloskiLCPrevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United StatesClin. Vaccin. Immunol.20142111912510.1128/CVI.00717-13
- ZeddemanAInvestigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012Euro Surveill20141911110.2807/1560-7917.ES2014.19.33.20881
- LeiningerEPertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cellsProc. Natl Acad. Sci. USA19918834534910.1073/pnas.88.2.34550807
- EverestPRole of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cellsMicrobiology19961423261326810.1099/13500872-142-11-3261
- EmsleyPCharlesIGFairweatherNFIsaacsNWStructure of Bordetella pertussis virulence factor P.69 pertactinNature1996381909210.1038/381090a0
- JunkerMPertactin beta-helix folding mechanism suggests common themes for the secretion and folding of autotransporter proteinsProc. Natl Acad. Sci. USA20061034918492310.1073/pnas.05079231031458770
- HovinghESEmerging Bordetella pertussis strains induce enhanced signaling of human pattern recognition receptors TLR2, NOD2 and secretion of IL-10 by dendritic cellsPLoS ONE201712e017002710.1371/journal.pone.01700275226795
- GuermonprezPValladeauJZitvogelLTheryCAmigorenaSAntigen presentation and T cell stimulation by dendritic cellsAnnu. Rev. Immunol.20022062166710.1146/annurev.immunol.20.100301.064828
- ChenJLiuZYangYIn vitro screening of LPS-induced miRNAs in leukocytes derived from cord blood and their possible roles in regulating TLR signalsPediatr. Res.20147559560210.1038/pr.2014.18
- Newton, K. & Dixit, V. M. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol4 (2012).
- RaevenRHPenningsJLvan RietEKerstenGFMetzBMeta-analysis of pulmonary transcriptomes from differently primed mice identifies molecular signatures to differentiate immune responses following Bordetella pertussis challengeJ. Immunol. Res.20172017851284710.1155/2017/85128475294382
- van GentMStudies on Prn variation in the mouse model and comparison with epidemiological dataPLoS ONE20116e1801410.1371/journal.pone.00180143064647
- PackardERPartonRCooteJGFryNKSequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UKJ. Med. Microbiol.20045335536510.1099/jmm.0.05515-0
- MenozziFDHeparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussisInfect. Immun.199462769778186182
- HijnenMThe role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognitionVaccine2007255902591410.1016/j.vaccine.2007.05.039
- PoolmanJTKuipersBVogelMLHamstraHJNagelJDescription of a hybridoma bank towards Bordetella pertussis toxin and surface antigensMicrob. Pathog.1990837738210.1016/0882-4010(90)90024-K
- BrummelmanJBordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cellsInfect. Immun.20158322723810.1128/IAI.02197-14
- MarimanRKremerBKoningFNagelkerkenLThe probiotic mixture VSL#3 mediates both pro- and anti-inflammatory responses in bone marrow-derived dendritic cells from C57BL/6 and BALB/c miceBr. J. Nutr.20141121088109710.1017/S000711451400169X
- MielcarekNLive attenuated B. pertussis as a single-dose nasal vaccine against whooping coughPLoS Pathog.20062e6510.1371/journal.ppat.00200651487175
- HovinghESAcquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surfacePLoS Pathog.201713e100653110.1371/journal.ppat.10065315542704
- EdgarRDomrachevMLashAEGene expression omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Res.20023020721010.1093/nar/30.1.20799122
- BartMJGlobal population structure and evolution of Bordetella pertussis and their relationship with vaccinationMBio20145e0107410.1128/mBio.01074-143994516
- LamCRapid increase in pertactin-deficient Bordetella pertussis isolates, AustraliaEmerg. Infect. Dis.2014206266333966384
- SafarchiAPertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection modelVaccine2015336277628110.1016/j.vaccine.2015.09.064
- BouchezVHegerleNStratiFNjamkepoEGuisoNNew data on vaccine antigen deficient Bordetella pertussis isolatesVaccines2015375177010.3390/vaccines30307514586476
- WilliamsMMBordetella pertussis strain lacking pertactin and pertussis toxinEmerg. Infect. Dis.20162231932210.3201/eid2202.1513324734536
- HegerleNDoreGGuisoNPertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccineVaccine2014326597660010.1016/j.vaccine.2014.09.068
- StefanelliPA natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cellsNew Microbiol.200932159166
- WarfelJMMerkelTJBordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primatesMucosal Immunol.2013678779610.1038/mi.2012.117
- RyanMDistinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in childrenImmunology19989311010.1046/j.1365-2567.1998.00401.x1364099
- InatsukaCSPertactin is required for Bordetella species to resist neutrophil-mediated clearanceInfect. Immun.2010782901290910.1128/IAI.00188-102897405
- LiJFairweatherNFNovotnyPDouganGCharlesIGCloning, nucleotide sequence and heterologous expression of the protective outer-membrane protein P.68 pertactin from Bordetella bronchisepticaJ. Gen. Microbiol.19921381697170510.1099/00221287-138-8-1697
- VisintinARegulation of toll-like receptors in human monocytes and dendritic cellsJ. Immunol.200116624925510.4049/jimmunol.166.1.249
- AlvarezJIInhibition of toll like receptor immune responses by microbial pathogensFront. Biosci.20051058258710.2741/1554
- van der AarAMLoss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognitionJ. Immunol.20071781986199010.4049/jimmunol.178.4.1986
- Hoces de la GuardiaAInflammatory cytokine and microRNA responses of primary human dendritic cells cultured with Helicobacter pylori strainsFront. Microbiol.2013423610.3389/fmicb.2013.002363747313
- ChenTMicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cellsFEBS Lett.201158556757310.1016/j.febslet.2011.01.010
- ParkHHuangXLuCCairoMSZhouXMicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteinsJ. Biol. Chem.20152902831284110.1074/jbc.M114.591420
- SedgerLMMcDermottMFTNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and futureCytokine Growth Factor Rev.20142545347210.1016/j.cytogfr.2014.07.016
- HiggsRHigginsSCRossPJMillsKHImmunity to the respiratory pathogen Bordetella pertussisMucosal Immunol.2012548550010.1038/mi.2012.54
- PaluckaKBanchereauJHow dendritic cells and microbes interact to elicit or subvert protective immune responsesCurr. Opin. Immunol.20021442043110.1016/S0952-7915(02)00365-5